Min‐Shao Tsai

413 total citations
11 papers, 337 citations indexed

About

Min‐Shao Tsai is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Min‐Shao Tsai has authored 11 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Plant Science. Recurrent topics in Min‐Shao Tsai's work include DNA Repair Mechanisms (4 papers), Phytochemistry and biological activity of medicinal plants (3 papers) and Cancer therapeutics and mechanisms (2 papers). Min‐Shao Tsai is often cited by papers focused on DNA Repair Mechanisms (4 papers), Phytochemistry and biological activity of medicinal plants (3 papers) and Cancer therapeutics and mechanisms (2 papers). Min‐Shao Tsai collaborates with scholars based in Taiwan. Min‐Shao Tsai's co-authors include Yun‐Wei Lin, Shao‐Hsing Weng, Jen‐Chung Ko, Szu‐Ting Lin, Chao‐Min Cheng, Ying-Jhen Su, Yu‐Ching Huang, Shih‐Ci Ciou, Hsin‐Bang Leu and Ying‐Hwa Chen and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Min‐Shao Tsai

11 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min‐Shao Tsai Taiwan 11 224 91 58 50 47 11 337
Shusuke Yasuda Japan 13 265 1.2× 72 0.8× 29 0.5× 24 0.5× 40 0.9× 23 418
Shao‐Hsing Weng Taiwan 13 266 1.2× 94 1.0× 27 0.5× 45 0.9× 16 0.3× 15 340
Shreya Kar Singapore 6 290 1.3× 138 1.5× 31 0.5× 18 0.4× 29 0.6× 8 500
Addanki P. Kumar United States 9 265 1.2× 69 0.8× 16 0.3× 46 0.9× 24 0.5× 10 432
Prabodh K. Kandala United States 10 246 1.1× 89 1.0× 20 0.3× 17 0.3× 41 0.9× 11 369
Min-Ting Lin China 8 301 1.3× 48 0.5× 34 0.6× 51 1.0× 14 0.3× 8 448
MyongHak Ri China 11 230 1.0× 108 1.2× 36 0.6× 14 0.3× 31 0.7× 12 447
Liuning Li China 12 286 1.3× 68 0.7× 29 0.5× 27 0.5× 12 0.3× 23 427
Ma'in Y. Maitah United States 8 397 1.8× 125 1.4× 35 0.6× 21 0.4× 15 0.3× 11 485
Samir Alhasan United States 11 218 1.0× 119 1.3× 44 0.8× 16 0.3× 25 0.5× 15 446

Countries citing papers authored by Min‐Shao Tsai

Since Specialization
Citations

This map shows the geographic impact of Min‐Shao Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Shao Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Shao Tsai more than expected).

Fields of papers citing papers by Min‐Shao Tsai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min‐Shao Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Shao Tsai. The network helps show where Min‐Shao Tsai may publish in the future.

Co-authorship network of co-authors of Min‐Shao Tsai

This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Shao Tsai. A scholar is included among the top collaborators of Min‐Shao Tsai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Shao Tsai. Min‐Shao Tsai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chiang, Ming‐Tsai, I‐Ming Chen, Fu‐Fei Hsu, et al.. (2020). Gal-1 (Galectin-1) Upregulation Contributes to Abdominal Aortic Aneurysm Progression by Enhancing Vascular Inflammation. Arteriosclerosis Thrombosis and Vascular Biology. 41(1). 331–345. 19 indexed citations
2.
Ko, Jen‐Chung, Yu‐Ching Huang, Shao‐Hsing Weng, et al.. (2012). HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells. Regulatory Toxicology and Pharmacology. 64(3). 415–424. 20 indexed citations
3.
Tsai, Min‐Shao, et al.. (2011). Inhibition of p38 MAPK-Dependent Excision Repair Cross-Complementing 1 Expression Decreases the DNA Repair Capacity to Sensitize Lung Cancer Cells to Etoposide. Molecular Cancer Therapeutics. 11(3). 561–571. 31 indexed citations
4.
Tsai, Min‐Shao, et al.. (2011). Synergistic Effect of Curcumin and Cisplatin via Down-Regulation of Thymidine Phosphorylase and Excision Repair Cross-Complementary 1 (ERCC1). Molecular Pharmacology. 80(1). 136–146. 39 indexed citations
5.
Ko, Jen‐Chung, et al.. (2011). Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2–ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells. Toxicology and Applied Pharmacology. 255(3). 327–338. 31 indexed citations
6.
7.
Weng, Shao‐Hsing, et al.. (2011). Enhancement of Mitomycin C‐Induced Cytotoxicity by Curcumin Results from Down‐Regulation of MKK1/2‐ERK1/2‐Mediated Thymidine Phosphorylase Expression. Basic & Clinical Pharmacology & Toxicology. 110(3). 298–306. 13 indexed citations
8.
Tsai, Min‐Shao, et al.. (2010). Down-Regulation of Rad51 Expression Overcomes Drug Resistance to Gemcitabine in Human Non–Small-Cell Lung Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 335(3). 830–840. 63 indexed citations
9.
Ko, Jen‐Chung, et al.. (2010). Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine. Biochemical Pharmacology. 81(5). 680–690. 23 indexed citations
10.
11.
Ko, Jen‐Chung, Ying-Jhen Su, Szu‐Ting Lin, et al.. (2009). Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2. Lung Cancer. 69(2). 155–164. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shusuke Yasuda Breakdown of academic impact, for papers by Shao‐Hsing Weng Breakdown of academic impact, for papers by Shreya Kar Breakdown of academic impact, for papers by Addanki P. Kumar Breakdown of academic impact, for papers by Prabodh K. Kandala Breakdown of academic impact, for papers by Min-Ting Lin Breakdown of academic impact, for papers by MyongHak Ri Breakdown of academic impact, for papers by Liuning Li Breakdown of academic impact, for papers by Ma'in Y. Maitah Breakdown of academic impact, for papers by Samir Alhasan
Rankless by CCL
2026